Introduction

In modern medicines (Allopathy), the drug discovery process works on investigating the synthetic new chemical entities or modifying the existing drugs against the targeted disease. In the current scenario, irrespective of the availability of advanced research techniques and drug discovery tools, the discovery of new drug candidates are not accelerated to a great extent. Hence, to overcome the limitations of modern drug discovery there is need of an alternate promising therapeutic segment.

It was observed that in the majority of human ailments the Phytopharmaceuticals and Nutraceuticals therapy is more effective and promising than existing allopathic treatment. Even though, the Pharmaceutical industry is not keen to work in this therapeutic segment, as intellectual property rights are not granted in this domain. Another reason behind their unwillingness to promote this segment is that they are not getting as much revenue as from modified drugs, patented drugs, and processes. In some instances, for increment in the product cost so as to get more profit, the Pharmaceutical industries unnecessary indulge in the isolation process of some components from Phytopharmaceuticals and Nutraceuticals source. Due to all these reasons, the real benefit of Phytopharmaceuticals and Nutraceuticals therapy remain unrecognized/hidden and it does not reach to the medical practitioners as well as to the patients.

RegenHealth Life Science Private Ltd constantly strives to provide the potential use of Phytopharmaceuticals and Nutraceuticals products in various therapeutic segments to achieve the unmet need of patients at an affordable cost. We as an organization believes in high ethical and social value work for patient welfare.